Hospital pillows, mattresses and duvets can become infected with a range of pathogens including Coronavirus (1). When the head or body is laid on the typical soft surface or is moved, air escapes the pillow and can contaminate the patient environment – creating a risk of cross-infection to patient and caregiver alike.
There has always been an important need, now more than ever, to ensure that textiles and soft furnishings provide barrier protection in the patient/caregiver environment.
Betsi Cadwaladr University Health Board in Wales has invested in CE Medical Device barrier bedding by equipping their facilities with SleepAngel mattresses, pillows and duvets. Clinically and scientifically proven (2) to be a 100% barrier to pathogens including Coronavirus, the Health Board has reduced infection risk and upgraded patient/caregiver protection by adopting SleepAngel.
“PneumaPure technology was created to fight HealthCare acquired infections. The combination of specialist materials and innovation – welded seams, liquid proof yet breathable cover material and nano porous filter composite – allow soft surfaces to be handled similarly as hard surfaces. They can be disinfected using standard protocols and used for other patients. As a result, costs related to traditional bedding (washing, transport, extra stock) are removed,” says SleepAngel / Gabriel Scientific founder and CEO Sven Jürisoo.
“It has been a pleasure to work with NHS Wales as they adopt SleepAngel barrier technology to protect patients and caregivers.” Steven Lardner, Global Business Director at SleepAngel / Gabriel Scientific.
Betsi Cadwaladr University Health Board
Betsi Cadwaladr University Health Board is the largest health organisation in Wales. Its mission is to improve health and deliver excellent care. https://bcuhb.nhs.wales/
SleepAngel / Gabriel Scientific
SleepAngel Products are patent protected and produced by Gabriel Scientific, a life sciences company specialising in filter-based infection prevention and control in over 30 countries worldwide. info@SleepAngel-Medical.com
- [Kaiser T, Finstermeier K, Häntzsch M et al, Stalking a lethal superbug by whole-genome sequencing and phylogenetics: Influence on unraveling a major hospital outbreak of carbapenem-resistant Klebsiella pneumoniae. Am J Infect Control. 2018 Jan;46(1):54-59. doi: 10.1016/j.ajic.2017.07.022. Epub 2017 Sep 19.] [Chen Y, He Y, Zhang W, et al Pathogenic characteristics of nosocomial infections in patients with cerebrovascular diseases and characteristics and treatment of pathogenic bacteria in different seasons. J Infect Public Health. 2019 Dec 9. pii: S1876-0341(19)30350-8. doi: 10.1016/j.jiph.2019.11.010. [Epub ahead of print]]
- Data on file – available upon request